Using stem cell-derived exosomes to prevent and treat spinal dural fibrosis
Preventive and Therapeutic Effects of Bone Marrow Stem Cell-Derived Exosomes on Spine Dural Fibrosis
This study is looking at how tiny particles from bone marrow stem cells might help reduce painful scar tissue that can form after spinal surgery, which could lead to better recovery for patients dealing with chronic pain and weakness.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-10620150 on NIH RePORTER |
What this research studies
This research investigates the use of exosomes derived from bone marrow stem cells to address spinal dural fibrosis, a condition that can occur after spinal surgery and lead to chronic pain and weakness. The study aims to understand how these exosomes can inhibit the formation of fibrous tissue that compresses nerves and the dura mater, potentially improving patient outcomes. By focusing on the paracrine signaling properties of exosomes, the research seeks to provide a less invasive treatment option compared to traditional stem cell therapies. Patients may be monitored for changes in symptoms and overall spinal health as part of the research.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have undergone spinal surgery and are experiencing symptoms related to failed back surgery syndrome.
Not a fit: Patients who have not had spinal surgery or do not exhibit symptoms of spinal dural fibrosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, effective treatments for patients suffering from chronic pain and complications after spinal surgery.
How similar studies have performed: Previous research has shown promising results using stem cell-derived exosomes in reducing fibrosis in other tissues, suggesting potential for success in this novel application.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Seol, Dong Rim — University of Iowa
- Study coordinator: Seol, Dong Rim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.